Buprenorphine Dispensing after Elimination of the Waiver Requirement

N Engl J Med. 2024 Apr 25;390(16):1530-1532. doi: 10.1056/NEJMc2312906.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, P.H.S.
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Buprenorphine* / therapeutic use
  • Drug Prescriptions / statistics & numerical data
  • Drug and Narcotic Control* / legislation & jurisprudence
  • Drug and Narcotic Control* / statistics & numerical data
  • Drug and Narcotic Control* / trends
  • Health Policy / legislation & jurisprudence
  • Humans
  • Narcotic Antagonists* / therapeutic use
  • Opiate Substitution Treatment* / statistics & numerical data
  • Opiate Substitution Treatment* / trends
  • Opioid-Related Disorders* / drug therapy
  • United States / epidemiology

Substances

  • Buprenorphine
  • Narcotic Antagonists